Showing results (591-600 of 703) with videos related to

Sort By:
Pageof 71
Transfusion|June 25, 2016
Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) studyMark H Yazer, Bryon Jackson, Neil Beckman, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Viruses|June 28, 2023
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 VariantsYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Blood|December 21, 2011
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphomaCraig H Moskowitz, Matt J Matasar, Andrew D Zelenetz, et al.
International Journal of Molecular Sciences|July 12, 2025
A Novel Pathogenic Variant Identified in HIKESHI-Related Hypomyelinating Leukodystrophy Disrupts Heat Shock Response in iPSCsMahmood Ali Saleh, Maria Boichuck, Aner Ottolenghi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 6, 2025
Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative reportJillian R Gunther, Joanna C Yang, Carla Hajj, et al.
The Journal of Biological Chemistry|May 26, 2001
Molecular defects underlying the Kell null phenotypeS Lee, D C Russo, A P Reiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcomePatrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Pathogens (Basel, Switzerland)|August 28, 2021
Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 InfectionTheodor Chitlaru, Erez Bar-Haim, Liat Bar-On, et al.
Palliative Medicine|March 25, 2021
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapyLiza Barki-Harrington, Orna Baron-Epel, Adir Shaulov, et al.
Pageof 71